期刊文献+

重组幽门螺旋杆菌黏附素A的可溶性表达、纯化及其免疫学性质分析

Soluble expression,purification and immunological properties of recombinant H.pylori adhesin A
原文传递
导出
摘要 目的 通过分子克隆、蛋白表达及纯化等技术获得重组幽门螺旋杆菌黏附素A(recombinant H.pylori adhesin A,rHpaA),免疫BALB/c小鼠,制备anti-HpaA多克隆抗体后,分析其抗体特异性。方法 利用Phyre2和DNAstar生物信息学软件分析rHpaA的三维结构及抗原性质;通过PCR长片段DNA合成技术获得黏附素HpaA基因,插入质粒pCzn1中,制备重组质粒pCzn1-rHpaA,转化E.coli Arctic Express(DE3),经IPTG诱导表达、Ni-IDA亲和层析纯化后,获得rHpaA蛋白,Western blot鉴定其反应原性。将rHpaA辅以弗氏佐剂免疫雄性BALB/c小鼠,共6只,制备antiHpaA多克隆抗体,ELISA法鉴定其抗体特异性。结果 rHpaA具有较好的三维结构及抗原性质。双酶切鉴定及基因测序证明,重组质粒pCzn1-rHpaA含有完全正确的HpaA基因序列。重组菌株pCzn1-rHpaA/Arctic Express可溶性表达目的蛋白rHpaA,约占上清总蛋白的68.3%,纯度达98.1%。rHpaA可与anti-His和anti-H.pylori抗体相结合;antiHpaA多克隆抗体可特异性识别rHpaA和H.pylori裂解物。结论 经低温诱导表达和蛋白纯化等技术,可获得高纯度目的蛋白rHpaA,制备的anti-HpaA多克隆抗体具有良好的特异性,为研究H.pylori相关诊断试剂奠定了实验基础。 ObjectiveTo obtain recombinant H.pylori adhesin A(rHpaA)by molecular cloning,protein expression and purification,immunize BALB/c mice to prepare anti-HpaA polyclonal antibody,and analyze its antibody specificity.MethodsThe three-dimensional structure and antigenic properties of rHpaA were analyzed by bioinformatics softwares such as Phyre2 and DNAstar;Adhesin HpaA gene was obtained by PAS(PCR-based accurate synthesis)and inserted into plasmid pCzn1.The prepared recombinant plasmid pCzn1-rHpaA was transformed to E.coli Artic Express(DE3),induced by IPTG and purified by Ni-IDA affinity chromatography to obtain rHpaA protein,which was identified for reactivity by Western blot.Six male BALB/c mice were immunized with rHpaA plus Freund's adjuvant to prepare anti-HpaA polyclonal anti-body,and the antibody specificity was identified by ELISA.ResultsrHpaA showed good three-dimensional structure and antigenic properties.Restriction analysis and gene sequencing showed that the recombinant plasmid pCzn1-rHpaA contained completely correct HpaA gene sequence.The recombinant strain pCzn1-rHpaA/Arctic Express expressed the soluble target protein rHpaA,which accounted for about 68.3% of total protein in the supernatant,with a purity of 98.1%.rHpaA bound to anti-His antibodies and anti-H.pylori antibodies;The anti-HpaA polyclonal antibody specifically recognized rHpaA and H.pylori lysates.ConclusionrHpaA protein with high purity can be obtained by induction at low temperature and purification.The prepared anti-HpaA polyclonal antibody had good specificity,which laid an experimental foundation of the development of H.pylori-related diagnostic reagents.
作者 刘昆梅 张富蕊 李欣 张国林 刘宏鹏 郭乐 LIU Kunmei;ZHANG Furui;LI Xin;ZHANG Guolin;LIU Hongpeng;GUO Le(Breeding Base of State Key Laboratory for Craniocerebral Diseases,Ningxia Medical University,Yinchuan 750021,Ningxia Hui Autonomous Region,China;不详)
出处 《中国生物制品学杂志》 CAS CSCD 北大核心 2023年第3期310-314,共5页 Chinese Journal of Biologicals
基金 国家自然科学基金(32070930、82160497) 宁夏重点研发计划(2020BFG02012) 宁夏自然科学基金(2022AAC02034) 宁夏高等学校科学研究项目(NGY2020043)。
关键词 幽门螺旋杆菌黏附素A 表达 纯化 多克隆抗体 H.pylori adhesin A(HpaA) Expression Purification Polyclonal antibody
  • 相关文献

参考文献1

二级参考文献11

  • 1WenGao,HongCheng,FulianHu,JiangLi,LihuiWang,GuibinYang,LeXu,XiaoliZheng.The Evolution of Helicobacter pylori Antibiotics Resistance Over 10 Years in Beijing, China[J]. Helicobacter . 2010 (5)
  • 2E Robert Greenberg,Garnet L Anderson,Douglas R Morgan,Javier Torres,William D Chey,Luis Eduardo Bravo,Ricardo L Dominguez,Catterina Ferreccio,Rolando Herrero,Eduardo C Lazcano-Ponce,María Mercedes Meza-Montenegro,Rodolfo Pe?a,Edgar M Pe?a,Eduardo Salazar-Martínez,Pelayo Correa,María Elena Martínez,Manuel Valdivieso,Gary E Goodman,John J Crowley,Laurence H Baker.14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial[J].The Lancet.2011(9790)
  • 3Jyh-Chin Yang,Hung-Chih Yang,Chia-Tung Shun,Teh-Hong Wang,Chiang-Ting Chien,John Y. Kao,Yong Chool Boo.Catechins and Sialic Acid Attenuate Helicobacter pylori -Triggered Epithelial Caspase-1 Activity and Eradicate Helicobacter pylori Infection[J].Evidence-Based Complementary and Alternative Medicine.2013
  • 4M. Sugimoto,N. Shirai,M. Nishino,C. Kodaira,T. Uotani,M. Yamade,S. Sahara,H. Ichikawa,K. Sugimoto,H. Miyajima,T. Furuta.Rabeprazole 10?mg q.d.s. decreases 24‐h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40?mg o.m., overcoming CYP 2 C 19 genotype[J].Aliment Pharmacol Ther.2012(7)
  • 5Wenming Wu,Yunsheng Yang,Gang Sun,Ping-I Hsu.Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication[J].Gastroenterology Research and Practice.2012
  • 6D. J.Touw,R. H.Schaik.A comparison of the acid‐inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2C19 polymorphism[J].Aliment Pharmacol Ther.2012(7)
  • 7Jun‐WonChung,Gin HyugLee,Jin‐YongJeong,Sun MiLee,Ji HoonJung,Kee DonChoi,Ho JuneSong,Hwoon‐YongJung,Jin‐HoKim.Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance[J].Journal of Gastroenterology and Hepatology.2012(3)
  • 8Seung YoungKim,Sung WooJung,Jeong HanKim,Ja SeolKoo,Hyung JoonYim,Jong JaePark,Hoon JaiChun,Sang WooLee,Jai HyunChoi.Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea[J].British Journal of Clinical Pharmacology.2011(1)
  • 9F.F. Vale,J.M.B. Vítor.Transmission pathway of Helicobacter pylori : Does food play a role in rural and urban areas?[J].International Journal of Food Microbiology.2010(1)
  • 10Deng–Chyang Wu,Ping–I. Hsu,Jeng–Yih Wu,Antone R. Opekun,Chao–Hung Kuo,I.–Chen Wu,Sophie S.W. Wang,Angela Chen,Wen–Chun Hung,David Y. Graham.Sequential and Concomitant Therapy With Four Drugs Is Equally Effective for Eradication of H pylori Infection[J].Clinical Gastroenterology and Hepatology.2010(1)

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部